CD101

· Cidara Therapeutics, Inc. (a subsidiary of Merck & Co., Inc.)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CD101, covering 2017-06-26 to 2024-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Single Ascending Dose Study of CD101 IV in Healthy Subjects [Phase 1]